The National Agency for Food and Drug Administration and Control (NAFDAC) in a move to safeguard the interests of the Nigerian Pharmaceutical sector has issued a stern warning against the illegal importation of syringes from foreign countries. The agency, led by Director-General Prof Mojisola Adeyeye, aims to prevent potential damage to the local pharmaceutical industry.
NAFDAC’s cautionary stance was communicated during a meeting with the newly appointed executive members of the Association of Nigerian Licensed Customs Agents (ANLCA). The agency emphasized the crucial role of customs agents in prioritizing national interests over personal gains, especially in preventing the influx of unauthorized syringes into the Nigerian market.
Prof Adeyeye urged customs agents to collaborate with NAFDAC to address challenges related to the rejection of Nigerian food exports by Western nations. The director-general highlighted the importance of unity in overcoming these hurdles and promoting the growth of the country’s industries.
During a recent facility tour, Prof Adeyeye expressed admiration for the substantial investments made by a local pharmaceutical company in the production of syringes within Nigeria. The facilities showcased during the tour were deemed comparable to international standards found in the US and Europe. However, she raised concerns about the excess inventory of over 1.5 billion units of locally produced syringes lying unsold in warehouses.
The NAFDAC boss attributed this surplus to the negative impact of imported syringes flooding the market. Despite protective measures such as imposing high import duties on syringes, the influx of foreign products continues to hamper the growth and sales of locally manufactured medical supplies.
In light of these challenges, NAFDAC’s warning serves as a call to action for customs agents to be vigilant against complicity in the illegal importation of syringes. The agency advocates for concerted efforts to protect the local pharmaceutical industry and ensure the safety and reliability of medical products circulating within the country.
